BlackRock Inc. - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$127,326
-59.6%
271,484
-5.3%
0.00%
Q2 2023$315,404
-43.6%
286,731
-39.0%
0.00%
Q1 2023$559,486
-5.8%
470,157
+17.9%
0.00%
Q4 2022$594,134
-7.9%
398,748
+0.9%
0.00%
Q3 2022$645,000
+103.5%
395,378
-0.9%
0.00%
Q2 2022$317,000
-53.7%
399,040
+4.8%
0.00%
Q1 2022$685,000
+0.6%
380,829
-4.5%
0.00%
Q4 2021$681,000
-14.6%
398,899
+3.1%
0.00%
Q3 2021$797,000
-0.4%
386,935
+11.7%
0.00%
Q2 2021$800,000
-79.6%
346,556
-75.3%
0.00%
Q1 2021$3,920,000
+1.6%
1,405,038
+3.8%
0.00%
Q4 2020$3,857,000
+39.3%
1,353,018
+2.7%
0.00%
Q3 2020$2,768,000
-54.0%
1,317,460
-0.3%
0.00%
Q2 2020$6,013,000
-45.1%
1,321,593
-1.4%
0.00%
-100.0%
Q1 2020$10,957,000
-56.1%
1,341,025
-1.4%
0.00%0.0%
Q4 2019$24,932,000
+71.3%
1,360,118
+3.6%
0.00%0.0%
Q3 2019$14,552,000
+10.7%
1,313,339
+1.6%
0.00%0.0%
Q2 2019$13,142,000
+99.4%
1,292,173
+14.9%
0.00%
Q1 2019$6,592,000
-19.6%
1,124,827
-2.6%
0.00%
Q4 2018$8,199,000
+5.6%
1,154,815
+5.7%
0.00%
Q3 2018$7,764,000
+35.1%
1,092,028
-4.6%
0.00%
Q2 2018$5,747,000
-41.8%
1,144,988
+27.6%
0.00%
Q1 2018$9,880,000
+5.6%
897,429
-11.3%
0.00%
Q4 2017$9,359,000
+4.4%
1,011,855
+1.4%
0.00%
Q3 2017$8,961,000
+30.4%
998,056
+2.1%
0.00%
Q2 2017$6,873,000
+170.4%
977,590
+236.1%
0.00%
Q1 2017$2,542,000290,8520.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders